Effects of Vascular Endothelial Growth Factor Signaling Inhibition on Human Erythropoiesis

Inhibition of vascular endothelial growth factor (VEGF) signaling increases red blood cell (RBC) counts, and erythropoiesis markers have been proposed to guide antiangiogenic therapy in humans. We analyzed RBC measurements in patients enrolled in three studies: a phase II trial of axitinib in thyroi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bhatta, Sumita S., Wroblewski, Kristen E., Agarwal, Kelly L., Sit, Laura, Cohen, Ezra E.W., Seiwert, Tanguy Y., Karrison, Theodore, Bakris, George L., Ratain, Mark J., Vokes, Everett E., Maitland, Michael L.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2013
Teme:
New Drug Development and Clinical Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3755935/
https://ncbi.nlm.nih.gov/pubmed/23900000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0006
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items